<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03771235</url>
  </required_header>
  <id_info>
    <org_study_id>2018-30</org_study_id>
    <nct_id>NCT03771235</nct_id>
  </id_info>
  <brief_title>Online Mindfulness-based Tic Reduction (Phase Two)</brief_title>
  <official_title>Online Mindfulness-based Tic Reduction: Development and Testing (Phase Two)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bowdoin College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bowdoin College</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially
      disabling neurobiological conditions. Although a range of pharmacological and psychosocial
      treatments exists, a significant number of individuals either do not respond to the current
      treatments or find them unacceptable. Thus, it is essential that researchers continue to
      develop and test novel treatment approaches.

      In this randomized controlled trial the investigators will compare two different online
      group-based interventions for tics: a mindfulness-based program (Mindfulness-based
      Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic
      Information and Coping Strategies (TICS)). The purpose of this study is to determine which
      intervention is more helpful for adults with a tic disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Yale Global Tic Severity Scale (YGTSS) Total Tic Severity Score</measure>
    <time_frame>Screening, Week 0, Week 9, Week 13, Week 35</time_frame>
    <description>Clinician-rated measure of tic severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impressions Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adult Tic Questionnaire</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attention-Deficit Hyperactivity Rating Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Anxiety Stress Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Premonitory Urge to Tic Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tic Rating Form</measure>
    <time_frame>Weeks 1-8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problem Rating Form</measure>
    <time_frame>Weeks 1-8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire-9</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work and Social Adjustment Survey</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Five Facet Mindfulness Questionnaire</measure>
    <time_frame>Weeks 0, 4, 8, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Credibility and Expectancy Questionnaire</measure>
    <time_frame>Week 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire</measure>
    <time_frame>Week 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self Compassion Scale</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Affective Reactivity Index</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Irritability Test</measure>
    <time_frame>Weeks 0, 9, 13, 35</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Tourette Syndrome</condition>
  <condition>Persistent Tic Disorder</condition>
  <arm_group>
    <arm_group_label>Mindfulness-based Intervention for Tics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8-week group-based mindfulness-based program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tic Information and Coping Strategies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-week group-based educational and supportive therapy program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-based Intervention for Tics</intervention_name>
    <description>Psychological intervention that focuses on cultivating awareness of urges to tic and developing a different relationship to those urges through meditation and other mindfulness practices.</description>
    <arm_group_label>Mindfulness-based Intervention for Tics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tic Information and Coping Strategies</intervention_name>
    <description>Psychological Intervention that focuses on learning more about tics, practicing a range of strategies for coping with tics (e.g., relaxation, effective communication), and discussing challenges commonly experienced by individuals with tics.</description>
    <arm_group_label>Tic Information and Coping Strategies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. be 18 years of age or older,

          2. possess a primary diagnosis of Tourette Syndrome or Persistent Tic Disorder,

          3. be fluent in English

          4. reside in the United States,

          5. either not be taking any tic suppressant medication or other psychotropic medication
             or be at a stable dose for 8 weeks prior to the baseline assessment and throughout the
             study

        Exclusion Criteria:

          1. be receiving concurrent psychotherapy for the duration of the study

          2. have prior extensive experience with mindfulness and/or meditation and

          3. have another medical or psychological condition that would prevent the individual from
             fully engaging in the study or require a higher level of care (e.g., suicidality).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannah Reese, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannah Reese, Ph.D.</last_name>
    <phone>207-798-4146</phone>
    <email>hreese@bowdoin.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Miller, B.A.</last_name>
    <phone>617-724-4354</phone>
    <email>smiller43@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bowdoin College</name>
      <address>
        <city>Brunswick</city>
        <state>Maine</state>
        <zip>04011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Reese, Ph.D.</last_name>
      <phone>207-798-4146</phone>
      <email>hreese@bowdoin.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Miller, B.A.</last_name>
      <phone>617-724-4354</phone>
      <email>smiller43@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Sabine Wilhelm, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 7, 2018</study_first_submitted>
  <study_first_submitted_qc>December 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2018</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bowdoin College</investigator_affiliation>
    <investigator_full_name>Hannah Reese</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Tourette Syndrome</keyword>
  <keyword>Tic Disorder</keyword>
  <keyword>Online</keyword>
  <keyword>Adults</keyword>
  <keyword>Mindfulness</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tourette Syndrome</mesh_term>
    <mesh_term>Tics</mesh_term>
    <mesh_term>Tic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

